Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Breast
Study Name
BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Principal Investigator
Gordan Srkalovic, MD, PhD
Study Information
https://www.clinicaltrials.gov/ct2/show/NCT02488967?term=BR003&rank=3
Contact for Questions
Nurse - Tracy 517-364-2835

Site view: at a glance